Mean platelet volume is independently associated with renal dysfunction in stable coronary artery disease

Hakan Uçar1, Mustafa Gür, Nermin Yildiz Koyunsever

  • 1Department of Cardiology, Adana Numune Training and Research Hospital , Adana/Turkey.

Platelets
|June 19, 2013
PubMed

Insights

Mean platelet volume (MPV) increases with declining estimated glomerular filtration rate (eGFR) in patients with coronary artery disease. This association may contribute to higher athero-thrombotic risk in those with impaired kidney function.

Area of Science:

  • Nephrology
  • Cardiology
  • Hematology

Background:

  • Athero-thrombotic risk increases with declining glomerular filtration rate (GFR).
  • Mean platelet volume (MPV) is a risk factor for athero-thrombotic events.
  • The relationship between GFR and MPV in stable coronary artery disease (CAD) needs further elucidation.

Purpose of the Study:

  • To investigate the association between estimated GFR and MPV in patients with stable CAD.
  • To determine if MPV is independently related to eGFR in this population.

Main Methods:

  • 471 patients with angiographically proven CAD were included.
  • Patients were divided into GFRlow (eGFR <60 ml/min/1.73 m²) and GFRhigh (eGFR ≥60 ml/min/1.73 m²) groups.
  • MPV, hs-CRP, and other biochemical markers were measured; eGFR was calculated using the Cockcroft-Gault formula.

Main Results:

  • The GFRlow group had higher MPV, hs-CRP, BMI, and prevalence of diabetes, hypertension, and hyperlipidemia.
  • Multivariate regression revealed MPV was independently associated with diabetes (β=0.189, p<0.001), eGFR (β=-0.267, p<0.001), hs-CRP (β=0.158, p<0.001), and platelet count (β=-0.116, p=0.002).

Conclusions:

  • MPV is independently associated with eGFR, hs-CRP, platelet count, and diabetes in patients with stable CAD.
  • These findings suggest a link between impaired renal function and increased athero-thrombotic risk via MPV.
  • MPV may serve as a biomarker for assessing athero-thrombotic risk in patients with varying degrees of renal function.

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...